Tested batch: EP-260512-MC10
MOTS-C is a mitochondrial-derived peptide consisting of 16 amino acids (Lee et al., 2015). Each box contains 10 vials of lyophilized powder, with 10mg per vial. This peptide is supplied as a research compound for laboratory use only.
Specifications: SKU MC10 · 10 vials of lyophilised powder per box · 10mg per vial · measured net content 11.02 mg. Testing: four Kovera Labs reports for batch EP-260512-MC10: RP-HPLC purity 99.303% with LC-MS identity, endotoxin < 0.20 EU/mL, heavy metals and sterility – see the certificates below. Further reading: MOTS-C in Australia: product overview and MOTS-C: a research guide to evaluating suppliers. For laboratory research use only; not for human consumption.
Free shipping on all products.
This product is strictly intended for laboratory research use only. Not for human consumption. All products sold are for research purposes and should only be handled by qualified professionals in a controlled laboratory environment.
Tested batch: EP-260512-MC10 · 4 published certificates. Report library updated .
Batch EP-260512-MC10 – four Kovera Labs reports. Purity and identity: RP-HPLC purity 99.303%, net content 11.02 mg, LC-MS identity: MOTS-c (KVR-2026-D397BE, 30 June 2026). Endotoxin: < 0.20 EU/mL (ENDO-KVR-2026-D397BE). Heavy metals: lead < 0.5, arsenic < 0.15, cadmium < 0.05 and mercury < 0.3 ppm (HM-KVR-2026-D397BE). Sterility: no bacterial growth (aerobic and anaerobic) and no fungi or yeast detected after a 2-day incubation (RSTER-KVR-2026-D397BE). Each certificate links to its Kovera Labs verification record, and the product image shows the same batch reference. For laboratory research use only.
| Test | Reported result | Report ID | Report date |
|---|---|---|---|
| Purity and Identity (COA) | Purity: 99.303 %; Net content: 11.02 mg; Identity confirmation: MOTS-c | KVR-2026-D397BE | 30 June 2026 |
| Endotoxin | Endotoxin: < 0.20 EU/mL | ENDO-KVR-2026-D397BE | 30 May 2026 |
| Heavy Metals | Lead: < 0.5 ppm; Arsenic: < 0.15 ppm; Cadmium: < 0.05 ppm; Mercury: < 0.3 ppm | HM-KVR-2026-D397BE | 31 May 2026 |
| Sterility testing | Bacteria (aerobic/anaerobic): No Growth; Fungi / yeast: Not Detected; Incubation period: 2 days | RSTER-KVR-2026-D397BE | 30 May 2026 |
Read how to interpret and verify a Kovera Labs report or browse our testing standards and report directory.
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Purity | 99.303 % | — | RP-HPLC |
| Net content | 11.02 mg | — | — |
| Identity confirmation | MOTS-c | — | LC-MS |
| Endotoxin screen | PASS | — | — |
| Microbial sterility screen | No Growth | — | — |
| Arsenic (As) screening | Negative | — | — |
| Cadmium (Cd) screening | Negative | — | — |
| Lead (Pb) screening | Negative | — | — |
| Mercury (Hg) screening | Negative | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Endotoxin | < 0.20 EU/mL | ≤ 0.5 | — |
| Final determination | PASS | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Lead | < 0.5 ppm | ≤ 10 | ICP-MS |
| Arsenic | < 0.15 ppm | ≤ 1.5 | ICP-MS |
| Cadmium | < 0.05 ppm | ≤ 0.5 | ICP-MS |
| Mercury | < 0.3 ppm | ≤ 3 | ICP-MS |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Bacteria (aerobic/anaerobic) | No Growth | — | — |
| Fungi / yeast | Not Detected | — | — |
| Incubation period | 2 days | — | — |
| Temperature | 30-35C | — | — |
| Final determination | SAMPLE PASSES STERILITY SCREEN | — | — |
Evidence reviews and laboratory guides relevant to MOTS-C 10mg, plus the testing behind each batch.
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a 16-amino-acid peptide encoded by a short open reading frame within the mitochondrial 12S rRNA gene (Lee et al., 2015). It was first described in 2015, in a study that used cultured cells and mouse models to examine its effects on cellular metabolism (Lee et al., 2015).
A 2021 study examined MOTS-c in mice of different ages and reported effects on skeletal-muscle metabolism and nuclear gene expression in those animals. The same paper reported that exercise increased endogenous MOTS-c in human skeletal muscle and circulation (Reynolds et al., 2021). Those human measurements concern the body's own peptide, not an administered peptide, and the mouse findings do not show effects in people.
About the evidence. Findings reported in published studies relate to the materials used in that work. This product is supplied by Eternal Peptides Wholesale for laboratory research use only and is not for human or veterinary use. Its Kovera Labs reports are published on this page and in the COA library.
Further reading: MOTS-c exercise research: evidence review
Further reading: How to read a peptide certificate of analysis
Explore MOTS-C research, Australian buying guides and laboratory documentation.
